• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喷昔洛韦抑制 SARS-CoV-2 机制的检测:分子动力学研究。

Inspection on the Mechanism of SARS-CoV-2 Inhibition by Penciclovir: A Molecular Dynamic Study.

机构信息

Department of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 00133 Rome, Italy.

出版信息

Molecules. 2022 Dec 26;28(1):191. doi: 10.3390/molecules28010191.

DOI:10.3390/molecules28010191
PMID:36615385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9821970/
Abstract

In recent years, humanity has had to face a critical pandemic due to SARS-CoV-2. In the rapid search for effective drugs against this RNA-positive virus, the repurposing of already existing nucleotide/nucleoside analogs able to stop RNA replication by inhibiting the RNA-dependent RNA polymerase enzyme has been evaluated. In this process, a valid contribution has been the use of in silico experiments, which allow for a rapid evaluation of the possible effectiveness of the proposed drugs. Here we propose a molecular dynamic study to provide insight into the inhibition mechanism of Penciclovir, a nucleotide analog on the RNA-dependent RNA polymerase enzyme. Besides the presented results, in this article, for the first time, molecular dynamic simulations have been performed considering not only the RNA-dependent RNA polymerase protein, but also its cofactors (fundamental for RNA replication) and double-strand RNA.

摘要

近年来,由于 SARS-CoV-2,人类不得不面对一场严重的大流行病。在快速寻找针对这种 RNA 阳性病毒的有效药物的过程中,评估了重新利用已经存在的核苷酸/核苷类似物,这些类似物可以通过抑制 RNA 依赖性 RNA 聚合酶酶来阻止 RNA 复制。在这个过程中,使用计算实验提供了有效的帮助,这使得可以快速评估所提出药物的可能有效性。在这里,我们提出了一项分子动力学研究,旨在深入了解喷昔洛韦(一种核苷酸类似物)对 RNA 依赖性 RNA 聚合酶酶的抑制机制。除了呈现的结果外,在本文中,首次进行了分子动力学模拟,不仅考虑了 RNA 依赖性 RNA 聚合酶蛋白,还考虑了其辅助因子(RNA 复制的基础)和双链 RNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/cb1005516499/molecules-28-00191-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/2613a881f5d9/molecules-28-00191-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/47b95e01c32d/molecules-28-00191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/6c4a91009d99/molecules-28-00191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/af7ba41531e4/molecules-28-00191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/fb3c717af022/molecules-28-00191-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/992a114273bc/molecules-28-00191-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/6a0493b22253/molecules-28-00191-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/cb1005516499/molecules-28-00191-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/2613a881f5d9/molecules-28-00191-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/47b95e01c32d/molecules-28-00191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/6c4a91009d99/molecules-28-00191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/af7ba41531e4/molecules-28-00191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/fb3c717af022/molecules-28-00191-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/992a114273bc/molecules-28-00191-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/6a0493b22253/molecules-28-00191-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc6/9821970/cb1005516499/molecules-28-00191-g007.jpg

相似文献

1
Inspection on the Mechanism of SARS-CoV-2 Inhibition by Penciclovir: A Molecular Dynamic Study.喷昔洛韦抑制 SARS-CoV-2 机制的检测:分子动力学研究。
Molecules. 2022 Dec 26;28(1):191. doi: 10.3390/molecules28010191.
2
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.重新利用非核苷类抗病毒药物治疗 SARS-CoV2 NSP12(RNA 依赖性 RNA 聚合酶):计算机分子洞察。
Biochem Biophys Res Commun. 2021 Sep 24;571:26-31. doi: 10.1016/j.bbrc.2021.07.050. Epub 2021 Jul 16.
3
State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.新冠病毒 RNA 依赖性 RNA 聚合酶的最新分子动力学模拟研究。
Int J Mol Sci. 2022 Sep 8;23(18):10358. doi: 10.3390/ijms231810358.
4
Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA.核苷类似物通过阻断病毒聚合酶与 RNA 的相互作用来抑制 SARS-CoV-2 复制。
Int J Mol Sci. 2023 Feb 8;24(4):3361. doi: 10.3390/ijms24043361.
5
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibition: an analysis.植物源天然多酚类化合物作为抗 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp)抑制剂的潜在抗病毒药物:分析。
J Biomol Struct Dyn. 2021 Oct;39(16):6249-6264. doi: 10.1080/07391102.2020.1796810. Epub 2020 Jul 28.
6
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an perspective.靶向 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp):一个研究视角。
J Biomol Struct Dyn. 2021 Jun;39(9):3204-3212. doi: 10.1080/07391102.2020.1761882. Epub 2020 May 6.
7
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).虫草素作为 SARS-CoV-2 依赖 RNA 的 RNA 聚合酶(RdRp)的一种有前途的抑制剂。
Curr Med Chem. 2022;29(1):152-162. doi: 10.2174/0929867328666210820114025.
8
On the Recognition of Natural Substrate CTP and Endogenous Inhibitor ddhCTP of SARS-CoV-2 RNA-Dependent RNA Polymerase: A Molecular Dynamics Study.新冠病毒 RNA 依赖的 RNA 聚合酶识别天然底物 CTP 和内源性抑制剂 ddhCTP:分子动力学研究。
J Chem Inf Model. 2022 Oct 24;62(20):4916-4927. doi: 10.1021/acs.jcim.2c01002. Epub 2022 Oct 11.
9
Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.针对 RNA 依赖性 RNA 聚合酶的 COVID-19 潜在靶点:全面综述。
Curr Pharm Biotechnol. 2022;23(3):396-419. doi: 10.2174/1389201022666210421102513.
10
Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses.SARS-cov-2 RNA 依赖性 RNA 聚合酶蛋白的潜在抑制剂:分子对接、分子动力学模拟和 MM-PBSA 分析。
J Biomol Struct Dyn. 2022 Jan;40(1):361-374. doi: 10.1080/07391102.2020.1813628. Epub 2020 Sep 2.

引用本文的文献

1
Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)NSP12中NSP7-NSP8结合位点的蛋白质-蛋白质相互作用及热点区域研究
Front Mol Biosci. 2024 Jan 18;10:1325588. doi: 10.3389/fmolb.2023.1325588. eCollection 2023.

本文引用的文献

1
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2.核苷(酸)类似物替诺福韦和恩曲他滨对 SARS-CoV-2 无效。
Molecules. 2022 Jun 30;27(13):4212. doi: 10.3390/molecules27134212.
2
study of natural compounds from sesame against COVID-19 by targeting M, PL and RdRp.通过靶向M、PL和RdRp研究芝麻中的天然化合物抗COVID-19的作用
RSC Adv. 2021 Jun 24;11(36):22398-22408. doi: 10.1039/d1ra03937g. eCollection 2021 Jun 21.
3
Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2.
苏拉明、喷昔洛韦和安尼拉非尼通过与 SARS-CoV-2 的 nsp12 结合在治疗 COVID-19 方面具有潜力。
J Biomol Struct Dyn. 2022;40(24):14067-14083. doi: 10.1080/07391102.2021.2000498. Epub 2021 Nov 16.
4
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral.加拉西韦(BCX4430)作为一种广谱抗病毒药物的研究进展更新。
Antiviral Res. 2021 Nov;195:105180. doi: 10.1016/j.antiviral.2021.105180. Epub 2021 Sep 20.
5
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.重新利用非核苷类抗病毒药物治疗 SARS-CoV2 NSP12(RNA 依赖性 RNA 聚合酶):计算机分子洞察。
Biochem Biophys Res Commun. 2021 Sep 24;571:26-31. doi: 10.1016/j.bbrc.2021.07.050. Epub 2021 Jul 16.
6
In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.基于 SARS-CoV-2 的 RNA 依赖性 RNA 聚合酶的计算机分析及现有抗病毒药物的治疗潜力。
Comput Biol Med. 2021 Aug;135:104591. doi: 10.1016/j.compbiomed.2021.104591. Epub 2021 Jun 23.
7
Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.SARS-CoV-2 复制过程中 Nsp7、Nsp8 和 Nsp12 的瞬时和稳定复合物。
Biophys J. 2021 Aug 3;120(15):3152-3165. doi: 10.1016/j.bpj.2021.06.006. Epub 2021 Jun 29.
8
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase.计算机模拟评估瑞德西韦、法匹拉韦、利巴韦林和加洛韦的活性形式对 SARS-CoV-2 RNA 聚合酶的潜在抑制活性。
Mol Divers. 2022 Feb;26(1):279-292. doi: 10.1007/s11030-021-10215-5. Epub 2021 Mar 25.
9
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic.RNA 依赖性 RNA 聚合酶(RdRp)抑制剂:当前的研究现状和在 COVID-19 大流行中的再利用。
Eur J Med Chem. 2021 Mar 5;213:113201. doi: 10.1016/j.ejmech.2021.113201. Epub 2021 Jan 21.
10
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.比较瑞德西韦及其代谢物与 SARS-CoV-2 病毒 NSP12-NSP7-NSP8 和 NSP3 的结合部位,以及 COVID-19 治疗的替代潜在药物。
Protein J. 2020 Dec;39(6):619-630. doi: 10.1007/s10930-020-09942-9. Epub 2020 Nov 13.